Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| hepatocyte | 4 studies | 65% ± 25% | |
| adipocyte | 4 studies | 27% ± 9% | |
| endothelial cell | 4 studies | 23% ± 5% | |
| oligodendrocyte | 4 studies | 26% ± 13% | |
| oligodendrocyte precursor cell | 3 studies | 18% ± 1% | |
| pericyte | 3 studies | 19% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| liver | 3 studies | 36% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 1523.42 | 226 / 226 | 95% | 42.11 | 387 / 406 |
| kidney | 92% | 109.00 | 82 / 89 | 75% | 9.45 | 679 / 901 |
| brain | 45% | 21.23 | 1182 / 2642 | 61% | 4.33 | 432 / 705 |
| thymus | 94% | 57.00 | 613 / 653 | 11% | 0.48 | 64 / 605 |
| bladder | 81% | 62.71 | 17 / 21 | 23% | 1.54 | 115 / 504 |
| breast | 99% | 197.67 | 456 / 459 | 3% | 0.21 | 30 / 1118 |
| adipose | 100% | 208.81 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| skin | 57% | 42.23 | 1034 / 1809 | 35% | 10.73 | 165 / 472 |
| intestine | 63% | 92.79 | 606 / 966 | 27% | 1.83 | 142 / 527 |
| blood vessel | 79% | 54.17 | 1049 / 1335 | 0% | 0 | 0 / 0 |
| lung | 54% | 21.18 | 315 / 578 | 17% | 1.25 | 194 / 1155 |
| pancreas | 2% | 0.40 | 5 / 328 | 57% | 4.59 | 102 / 178 |
| esophagus | 32% | 12.64 | 468 / 1445 | 25% | 1.53 | 46 / 183 |
| heart | 56% | 22.12 | 479 / 861 | 0% | 0 | 0 / 0 |
| stomach | 16% | 6.51 | 57 / 359 | 25% | 2.18 | 72 / 286 |
| muscle | 32% | 12.03 | 257 / 803 | 0% | 0 | 0 / 0 |
| uterus | 21% | 6.42 | 35 / 170 | 8% | 0.87 | 39 / 459 |
| ovary | 12% | 4.08 | 22 / 180 | 5% | 0.26 | 23 / 430 |
| prostate | 7% | 3.23 | 17 / 245 | 5% | 0.18 | 24 / 502 |
| adrenal gland | 1% | 1.23 | 3 / 258 | 7% | 0.36 | 15 / 230 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.10 | 1 / 29 |
| spleen | 1% | 2.68 | 2 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 1% | 0.50 | 5 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006643 | Biological process | membrane lipid metabolic process |
| GO_0019432 | Biological process | triglyceride biosynthetic process |
| GO_0046485 | Biological process | ether lipid metabolic process |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0050479 | Molecular function | glyceryl-ether monooxygenase activity |
| GO_0005506 | Molecular function | iron ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | AGMO |
| Protein name | Alkylglycerol monooxygenase Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195) |
| Synonyms | TMEM195 |
| Description | FUNCTION: Glyceryl-ether monooxygenase that cleaves the O-alkyl bond of ether lipids. Ether lipids are essential components of brain membranes. . FUNCTION: Glyceryl-ether monooxygenase that cleaves the O-alkyl bond of ether lipids. Ether lipids are essential components of brain membranes. . |
| Accessions | ENST00000418075.1 ENST00000342526.8 ENST00000407277.6 Q6ZNB7 H7C0E0 H0Y3V1 X5D773 |